Fong SJ - Search Results

1

Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay.

Urdea MS, Wilber JC, Yeghiazarian T, Todd JA, Kern DG, Fong SJ, Besemer D, Hoo B, Sheridan PJ, Kokka R, et al. Urdea MS, et al. Among authors: fong sj. AIDS. 1993 Nov;7 Suppl 2:S11-4. doi: 10.1097/00002030-199311002-00004. AIDS. 1993. PMID: 8161440

2

Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay.

Pachl C, Todd JA, Kern DG, Sheridan PJ, Fong SJ, Stempien M, Hoo B, Besemer D, Yeghiazarian T, Irvine B, et al. Pachl C, et al. Among authors: fong sj. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Apr 15;8(5):446-54. doi: 10.1097/00042560-199504120-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7697440

3

IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor.

Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, Lin L. Ralph P, et al. J Immunol. 1992 Feb 1;148(3):808-14. J Immunol. 1992. PMID: 1730874

4

Urokinase receptor antagonists: discovery and application to in vivo models of tumor growth.

Tressler RJ, Pitot PA, Stratton JR, Forrest LD, Zhuo S, Drummond RJ, Fong S, Doyle MV, Doyle LV, Min HY, Rosenberg S. Tressler RJ, et al. APMIS. 1999 Jan;107(1):168-73. doi: 10.1111/j.1699-0463.1999.tb01540.x. APMIS. 1999. PMID: 10190294

5

Parameters for the evaluation of long-term stability of tumour necrosis factor preparations.

Geigert J, Panschar BM, Taforo C, Paola J, Fong S, Huston HN, Wong DE, Wong DY. Geigert J, et al. Dev Biol Stand. 1988;69:129-38. Dev Biol Stand. 1988. PMID: 3224762

6

Random peptide bacteriophage display as a probe for urokinase receptor ligands.

Fong S, Doyle MV, Goodson RJ, Drummond RJ, Stratton JR, McGuire L, Doyle LV, Chapman HA, Rosenberg S. Fong S, et al. Biol Chem. 2002 Jan;383(1):149-58. doi: 10.1515/BC.2002.015. Biol Chem. 2002. PMID: 11928809

7

Response of bovine and porcine peripheral blood mononuclear cells to human recombinant interleukin 2(125).

Fong S, Doyle MV. Fong S, et al. Vet Immunol Immunopathol. 1986 Jan;11(1):91-100. doi: 10.1016/0165-2427(86)90091-7. Vet Immunol Immunopathol. 1986. PMID: 3485324

8

Potent, novel in vitro inhibitors of the Pseudomonas aeruginosa deacetylase LpxC.

Kline T, Andersen NH, Harwood EA, Bowman J, Malanda A, Endsley S, Erwin AL, Doyle M, Fong S, Harris AL, Mendelsohn B, Mdluli K, Raetz CR, Stover CK, Witte PR, Yabannavar A, Zhu S. Kline T, et al. J Med Chem. 2002 Jul 4;45(14):3112-29. doi: 10.1021/jm010579r. J Med Chem. 2002. PMID: 12086497

9

Comparison of the biological activities of human recombinant interleukin-2(125) and native interleukin-2.

Doyle MV, Lee MT, Fong S. Doyle MV, et al. J Biol Response Mod. 1985 Feb;4(1):96-109. J Biol Response Mod. 1985. PMID: 3920358

10

The long-term stability of recombinant (serine-17) human interferon-beta.

Geigert J, Panschar BM, Fong S, Huston HN, Wong DE, Wong DY, Taforo C, Pemberton M. Geigert J, et al. J Interferon Res. 1988 Aug;8(4):539-47. doi: 10.1089/jir.1988.8.539. J Interferon Res. 1988. PMID: 3171246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters